India's Emcure Pharma gains on Q3 profit jump

Emcure Pharmaceuticals

06/02/2025 09:46

** Shares of Emcure Pharma  EMCU.NS  climb 3% to 1,287.50
rupees
    ** Drugmaker reports 35.5% Y/Y growth in Q3 consol net
profit; rev from ops up ~18% Y/Y
    ** Its international business, biggest contributor to rev,
jumped 23% Y/Y, while domestic, second-biggest, rose 12% Y/Y
    ** Stock, however, down ~5% since trading debut in July 2024


 (Reporting by Kashish Tandon in Bengaluru)
 ((Kashish.tandon@thomsonreuters.com))